ciprofloxacin has been researched along with theophylline in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (28.05) | 18.7374 |
1990's | 39 (47.56) | 18.2507 |
2000's | 9 (10.98) | 29.6817 |
2010's | 11 (13.41) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cortijo, J; Gálvez, J; García-Domenech, R; Morcillo, E; Ríos-Santamarina, I; Santamaria, P | 1 |
Caron, G; Ermondi, G | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chyrek-Borowska, S; Michalska, I; Siergiejko, Z; Szymański, W | 1 |
Carnegie, CM; Lindsay, G; Scorer, HJ | 1 |
Gordon, T; Hamilton, RA | 1 |
Bader, MB | 1 |
Davis, RL; Kelly, HW; Powell, JR; Quenzer, RW | 1 |
LeBel, M; Parent, M | 1 |
FitzGerald, MX; O'Mahony, MS | 1 |
Goodwin, SD; Heyd, A; Nix, DE; Wilton, JH | 1 |
Allen, N; Semel, JD | 1 |
Goss, TF; Laughlin, PH; Nix, DE; Spivey, JM | 1 |
Michaud, R; Sesin, GP | 1 |
Flowers, MK; Taylor, DM | 1 |
LeBel, M; Parent, M; St-Laurent, M | 1 |
Christ, W | 1 |
Bachmann, KA; Sullivan, TJ | 1 |
Richardson, JP | 1 |
Atkinson, HC; Begg, EJ; Frampton, CM; Robson, RA; Saunders, DA | 1 |
Harris, JM | 1 |
Guzelian, PS; Hunt, C; Karnes, HT; Polk, RE; Sarkar, M | 1 |
Erickson, S; Paidipaty, B | 1 |
Bentley, DW; Karki, SD; Raghavan, M | 1 |
Pedersen, SS | 1 |
Polk, RE | 1 |
Healy, DP; Kanawati, L; Mooney, ML; Polk, RE; Rock, DT | 1 |
Adair, CG; Casabar, E; Kasik, JE; Lettieri, J; Prince, RA; Wexler, DB | 1 |
Eckert, G; Kropp, R | 1 |
Beer, C; Harder, S; Papenburg, A; Shah, PM; Staib, AH; Stille, W | 1 |
Rehavi, M; Rubinstein, E; Segev, S | 1 |
Baur, C; Davies, BI; Maesen, FP | 1 |
Bem, JL; Mann, RD | 1 |
Holden, R | 1 |
Bachmann, KA; Jauregui, L; Schwartz, JI | 1 |
Bachmann, K; Jauregui, L; Lettieri, J; Schwartz, J | 1 |
Duraski, RM | 1 |
Hepburn, M; Thomson, AH; Thomson, GD; Whiting, B | 1 |
Beer, C; Frech, K; Harder, S; Mieke, S; Shah, PM; Staib, AH; Stille, W | 1 |
Kawane, H; Niki, Y; Soejima, R; Sumi, M; Umeki, S | 1 |
Baars, AM; van Herwaarden, CL; Vree, TB; Wijnands, WJ | 2 |
Rubinstein, E; Segev, S | 1 |
Afzal, Q; Guarneri, JJ; Khan, FA; LaBombardi, V; Raoof, S; Wollschlager, CM | 1 |
DeVito, JM; Nix, DE; Schentag, JJ; Whitbread, MA | 1 |
Khan, FA; Raoof, S; Wollschlager, C | 1 |
Bowles, SK; Chandrasekar, PH; Edwards, DJ; Rybak, MJ | 1 |
Korrapati, MR; Muppalla, S; Vestal, RE; Wei, X; Zhai, S | 1 |
Batty, KT; Davis, TM; Dusci, LJ; Ilett, KF; Langton, SR | 1 |
Aarons, L; Davis, JD; Houston, JB | 2 |
Echevarria, KH | 1 |
Nightingale, CH; Zhi, J | 1 |
Embardo, LS; Rockwood, RP | 1 |
Climo, MW; Gillum, JG; Israel, DS; Polk, RE; Scott, RB | 1 |
Guanci, R; Lilley, LL | 1 |
Kunze, KL; Parker, BM; Vestal, RE; Wei, X; Zhai, S | 1 |
Haefeli, WE; Ritz, R; Schlienger, RG; Wyser, C | 1 |
de'Clari, F | 1 |
Cusack, BJ; Loi, CM; Parker, BM; Vestal, RE | 1 |
Cusack, BJ; Loi, CM; Parker, BM; Vestal, R | 1 |
Breisch, S; Chodosh, S; Lakshminarayan, S; Swarz, H | 1 |
Pons, G; Rey, E; Tréluyer, JM | 1 |
Hajime, N; Kamberi, M; Kamberi, P; Nakamura, K; Nakano, S; Uemura, N | 1 |
Amighi, K; Hamdani, J; Moës, AJ | 1 |
Aly, ZH; Radwan, MA; Zaghloul, IY | 1 |
Gagne, JJ; Maio, V; Rabinowitz, C | 1 |
Antoniou, T; Gomes, T; Juurlink, DN; Mamdani, MM | 1 |
Bellini, MS; Clavel, A; Lodi, A; Pijnenburg, N | 1 |
Lightstone, FC; Navid, A; Ng, DM; Wong, SE | 1 |
7 review(s) available for ciprofloxacin and theophylline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Meta-analysis of quinolone-theophylline interactions.
Topics: Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Meta-Analysis as Topic; Quinolones; Theophylline | 1991 |
Clinical efficacy of ciprofloxacin in lower respiratory tract infections.
Topics: Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Interactions; Humans; Lung Diseases, Obstructive; Meta-Analysis as Topic; Pneumonia, Mycoplasma; Respiratory Tract Infections; Theophylline | 1989 |
Drug-drug interactions with ciprofloxacin and other fluoroquinolones.
Topics: Antacids; Caffeine; Ciprofloxacin; Cyclosporins; Drug Interactions; Humans; Intestinal Absorption; Rifampin; Theophylline | 1989 |
Drug interactions of ciprofloxacin with other non-antibiotic agents.
Topics: Administration, Oral; Animals; Central Nervous System; Ciprofloxacin; Drug Interactions; Eukaryotic Cells; Humans; Intestinal Absorption; Theophylline | 1987 |
[Clinico-pharmacological case (4). Epileptic seizure as an unwanted drug effect on theophylline poisoning].
Topics: Aged; Atrial Fibrillation; Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Epilepsy; Humans; Male; Theophylline | 1996 |
Drug disposition in cystic fibrosis.
Topics: Absorption; Anti-Infective Agents; Ciprofloxacin; Cloxacillin; Cyclosporine; Cystic Fibrosis; Fleroxacin; Humans; Theophylline; Tissue Distribution | 1998 |
14 trial(s) available for ciprofloxacin and theophylline
Article | Year |
---|---|
[Effect of ofloxacin, ciprofloxacin and nalidixic acid on serum theophylline level in patients treated with methylxanthine preparations].
Topics: Administration, Oral; Adult; Aminophylline; Asthma; Biological Availability; Ciprofloxacin; Drug Therapy, Combination; Humans; Middle Aged; Nalidixic Acid; Ofloxacin; Theophylline; Time Factors | 1992 |
Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria; Ciprofloxacin; Double-Blind Method; Drug Interactions; Female; Fluoroquinolones; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Respiratory Tract Infections; Theophylline | 1992 |
Effect of the addition of ciprofloxacin on theophylline pharmacokinetics in subjects inhibited by cimetidine.
Topics: Adult; Cimetidine; Ciprofloxacin; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; Humans; Infusions, Intravenous; Liver; Male; Metabolic Clearance Rate; Theophylline | 1992 |
Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Fluoroquinolones; Humans; Male; Oxidation-Reduction; Quinolones; Random Allocation; Theophylline | 1990 |
Clinical efficacy of ciprofloxacin in lower respiratory tract infections.
Topics: Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Interactions; Humans; Lung Diseases, Obstructive; Meta-Analysis as Topic; Pneumonia, Mycoplasma; Respiratory Tract Infections; Theophylline | 1989 |
Effect of quinolone antimicrobials on theophylline pharmacokinetics.
Topics: Adult; Ciprofloxacin; Half-Life; Humans; Male; Metabolic Clearance Rate; Nalidixic Acid; Norfloxacin; Random Allocation; Theophylline | 1989 |
4-quinolones inhibit biotransformation of caffeine.
Topics: Adult; Biotransformation; Caffeine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Enoxacin; Humans; Male; Molecular Structure; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones; Random Allocation; Theophylline | 1988 |
[Gyrase inhibitors can delay caffeine elimination].
Topics: Caffeine; Ciprofloxacin; Enoxacin; Humans; Naphthyridines; Theophylline | 1986 |
Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Digestive System; Double-Blind Method; Female; Humans; Male; Middle Aged; Penicillin Resistance; Prospective Studies; Respiratory Tract Infections; Theophylline | 1987 |
Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green.
Topics: Administration, Oral; Ciprofloxacin; Drug Interactions; Half-Life; Humans; Indocyanine Green; Kinetics; Male; Random Allocation; Regression Analysis; Theophylline | 1987 |
Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Humans; Male; Theophylline | 1996 |
Relation between plasma and saliva concentrations of enoxacin, ciprofloxacin, and theophylline.
Topics: Adult; Anti-Infective Agents; Bronchodilator Agents; Ciprofloxacin; Drug Interactions; Enoxacin; Female; Humans; Male; Protein Binding; Saliva; Theophylline | 1996 |
Individual and combined effects of cimetidine and ciprofloxacin on theophylline metabolism in male nonsmokers.
Topics: Adult; Bronchodilator Agents; Cimetidine; Ciprofloxacin; Drug Interactions; Humans; Male; Smoking; Theophylline | 1993 |
Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Bronchodilator Agents; Chronic Disease; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Quinolones; Theophylline; Treatment Outcome | 1998 |
62 other study(ies) available for ciprofloxacin and theophylline
Article | Year |
---|---|
New bronchodilators selected by molecular topology.
Topics: Animals; Bronchodilator Agents; Discriminant Analysis; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Structure-Activity Relationship; Trachea | 1998 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Incidence and cost of hospital admissions secondary to drug interactions involving theophylline.
Topics: Aged; Aged, 80 and over; Cimetidine; Ciprofloxacin; Drug Interactions; Erythromycin; Health Care Costs; Hospitalization; Hospitals, Veterans; Humans; Male; New York; Patient Admission; Theophylline | 1992 |
Role of ciprofloxacin in fatal seizures.
Topics: Ciprofloxacin; Drug Interactions; Humans; Male; Middle Aged; Status Epilepticus; Theophylline | 1992 |
Cystic fibrosis and seizures.
Topics: Adult; Ciprofloxacin; Cystic Fibrosis; Humans; Seizures; Theophylline | 1991 |
Compatibility of ciprofloxacin injection with selected drugs and solutions.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Compounding; Drug Incompatibility; Drug Stability; Drug Storage; Drug Therapy, Combination; Gentamicins; Metronidazole; Solutions; Theophylline; Tobramycin | 1991 |
Seizures in patients simultaneously receiving theophylline and imipenem or ciprofloxacin or metronidazole.
Topics: Aged; Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Imipenem; Male; Metronidazole; Middle Aged; Monitoring, Physiologic; Seizures; Theophylline | 1991 |
Theophylline toxicity secondary to ciprofloxacin administration.
Topics: Aged; Charcoal; Ciprofloxacin; Drug Interactions; Female; Humans; Theophylline | 1991 |
Computer monitoring ciprofloxacin-theophylline interactions.
Topics: Ciprofloxacin; Computers; Drug Interactions; Humans; Theophylline | 1991 |
Variable theophylline clearance in cystic fibrosis.
Topics: Adult; Ciprofloxacin; Cystic Fibrosis; Drug Interactions; Humans; Male; Metabolic Clearance Rate; Theophylline | 1991 |
Safety of fleroxacin coadministered with theophylline to young and elderly volunteers.
Topics: Adult; Aged; Aging; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Fleroxacin; Humans; Male; Theophylline | 1990 |
Central nervous system toxicity of quinolones: human and animal findings.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Central Nervous System; Ciprofloxacin; Dogs; Drug Interactions; Fleroxacin; Fluoroquinolones; gamma-Aminobutyric Acid; Humans; Injections, Intraventricular; Narcotic Antagonists; Pefloxacin; Quinolizines; Seizures; Theophylline | 1990 |
Method for assessing the probability of toxicity from drug interactions having a pharmacokinetic basis.
Topics: Anti-Bacterial Agents; Cimetidine; Ciprofloxacin; Drug Interactions; Humans; Lactams; Models, Biological; Pharmacokinetics; Probability; Theophylline | 1990 |
Theophylline toxicity associated with the administration of ciprofloxacin in a nursing home patient.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Ciprofloxacin; Drug Interactions; Humans; Male; Nursing Homes; Theophylline; Urinary Tract Infections | 1990 |
Drug interactions affecting theophylline clearance.
Topics: Adolescent; Adult; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Propranolol; Theophylline | 1990 |
In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.
Topics: Biotransformation; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Hydroxylation; Microsomes, Liver; Norfloxacin; Theophylline; Uric Acid; Xanthines | 1990 |
Ciprofloxacin-theophylline drug interaction.
Topics: Aged; Aged, 80 and over; Ciprofloxacin; Drug Interactions; Female; Humans; Male; Theophylline | 1990 |
Seizure with ciprofloxacin and theophylline combined therapy.
Topics: Aged; Aged, 80 and over; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; Seizures; Theophylline | 1990 |
Interaction between oral ciprofloxacin and caffeine in normal volunteers.
Topics: Adult; Caffeine; Ciprofloxacin; Drug Interactions; Half-Life; Humans; Male; Theophylline | 1989 |
[Interaction of gyrase inhibitor with theophylline].
Topics: Aged; Ciprofloxacin; Delayed-Action Preparations; Drug Interactions; Humans; Middle Aged; Theophylline; Topoisomerase II Inhibitors | 1987 |
Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.
Topics: Animals; Ciprofloxacin; Diclofenac; Drug Synergism; GABA Antagonists; In Vitro Techniques; Male; Muscimol; Nalidixic Acid; Ofloxacin; Quinolones; Rats; Rats, Inbred Strains; Receptors, GABA-A; Theophylline | 1988 |
Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Ciprofloxacin; Drug Therapy, Combination; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Neisseriaceae; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Sputum; Streptococcus pneumoniae; Theophylline | 1986 |
Danger of interaction between ciprofloxacin and theophylline.
Topics: Adolescent; Adult; Aged; Ciprofloxacin; Drug Interactions; Female; Humans; Male; Middle Aged; Theophylline | 1988 |
Probable fatal interaction between ciprofloxacin and theophylline.
Topics: Aged; Ciprofloxacin; Drug Interactions; Female; Heart Rate; Humans; Liver; Theophylline | 1988 |
Predicting the ciprofloxacin-theophylline interaction from single plasma theophylline measurements.
Topics: Administration, Oral; Adult; Ciprofloxacin; Drug Interactions; Humans; Male; Theophylline | 1988 |
Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum.
Topics: Adult; Ciprofloxacin; Delayed-Action Preparations; Drug Interactions; Humans; Male; Theophylline | 1988 |
Ciprofloxacin-induced theophylline toxicity.
Topics: Aged; Aged, 80 and over; Ciprofloxacin; Drug Interactions; Female; Humans; Tachycardia, Supraventricular; Theophylline | 1988 |
A clinically significant interaction between ciprofloxacin and theophylline.
Topics: Aged; Aged, 80 and over; Ciprofloxacin; Drug Interactions; Humans; Male; Theophylline | 1987 |
New synthetic quinolone antibacterial agents and serum concentration of theophylline.
Topics: Adult; Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Theophylline | 1987 |
Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Enoxacin; Female; Humans; Male; Middle Aged; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Theophylline | 1987 |
The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Lung Diseases, Obstructive; Male; Metabolic Clearance Rate; Middle Aged; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Theophylline | 1987 |
Ciprofloxacin increases serum levels of theophylline.
Topics: Administration, Oral; Adult; Aged; Ciprofloxacin; Drug Interactions; Female; Humans; Injections, Intravenous; Male; Middle Aged; Theophylline | 1987 |
Increased theophylline concentrations secondary to ciprofloxacin.
Topics: Aged; Aged, 80 and over; Ciprofloxacin; Drug Interactions; Humans; Male; Theophylline | 1987 |
Simultaneous determination of theophylline, enoxacin and ciprofloxacin in human plasma and saliva by high-performance liquid chromatography.
Topics: Anti-Infective Agents; Bronchodilator Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Humans; Male; Reproducibility of Results; Saliva; Theophylline | 1995 |
The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.
Topics: Administration, Oral; Adolescent; Adult; Chromatography, High Pressure Liquid; Ciprofloxacin; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Fluorescence Polarization; Humans; Male; Metabolic Clearance Rate; Mixed Function Oxygenases; Oxidoreductases; Theophylline | 1995 |
Relationship between enoxacin and ciprofloxacin plasma concentrations and theophylline disposition.
Topics: Animals; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Infusions, Intravenous; Male; Rats; Rats, Sprague-Dawley; Theophylline | 1994 |
A warning on the use of Cipro.
Topics: Aged; Ciprofloxacin; Drug Interactions; Humans; Lung Diseases, Obstructive; Theophylline | 1994 |
Biphenylacetate, but not theophylline, lethally interacts with ciprofloxacin in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Drug Interactions; Female; Mice; Phenylacetates; Seizures; Theophylline | 1993 |
Simultaneous assay of fluoroquinolones and theophylline in plasma by high-performance liquid chromatography.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Male; Norfloxacin; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Theophylline | 1993 |
Theophylline, ciprofloxacin, erythromycin: a potentially harmful regimen.
Topics: Aged; Aged, 80 and over; Ciprofloxacin; Drug Interactions; Erythromycin; Humans; Theophylline | 1993 |
Avoiding adverse reactions.
Topics: Antacids; Anti-Infective Agents; Asthma; Bronchodilator Agents; Ciprofloxacin; Drug Interactions; Humans; Male; Middle Aged; Pneumonia; Theophylline | 1996 |
Ciprofloxacin was the culprit--not itraconazole.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bronchodilator Agents; Central Nervous System; Ciprofloxacin; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Humans; Itraconazole; Theophylline; Time Factors | 1997 |
Aging and drug interactions. III. Individual and combined effects of cimetidine and cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers.
Topics: Adult; Age Factors; Aged; Aging; Analysis of Variance; Biotransformation; Cimetidine; Ciprofloxacin; Creatinine; Drug Interactions; Female; Humans; Male; Metabolic Clearance Rate; Regression Analysis; Sex Characteristics; Theophylline | 1997 |
Simultaneous determination of grepafloxacin, ciprofloxacin, and theophylline in human plasma and urine by HPLC.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Interactions; Drug Monitoring; Fluoroquinolones; Humans; Piperazines; Reproducibility of Results; Sensitivity and Specificity; Theophylline | 1999 |
Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization.
Topics: Ciprofloxacin; Delayed-Action Preparations; Diglycerides; Drug Compounding; Excipients; Fatty Acids; Sodium Bicarbonate; Tetracycline; Theophylline | 2006 |
The effect of chronic cadmium exposure on the pharmacokinetics of theophylline and ciprofloxacin in rats.
Topics: Animals; Anti-Infective Agents; Bronchodilator Agents; Cadmium Chloride; Ciprofloxacin; Female; Humans; Male; Rats; Rats, Sprague-Dawley; Theophylline | 2007 |
Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Aminophylline; Anti-Inflammatory Agents, Non-Steroidal; Barbiturates; Child; Child, Preschool; Ciprofloxacin; Drug Interactions; Drug Utilization; Female; Fluvoxamine; Humans; Italy; Male; Middle Aged; Outpatients; Theophylline; Warfarin | 2008 |
Ciprofloxacin-induced theophylline toxicity: a population-based study.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Ciprofloxacin; Drug Interactions; Female; Humans; Male; Ontario; Pulmonary Disease, Chronic Obstructive; Theophylline | 2011 |
Determination of water content by capillary gas chromatography coupled with thermal conductivity detection.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Gas; Ciprofloxacin; European Union; Indicators and Reagents; Pharmaceutical Preparations; Solvents; Spectinomycin; Theophylline; Thermal Conductivity; Water | 2011 |
Application of a Physiologically Based Pharmacokinetic Model to Study Theophylline Metabolism and Its Interactions With Ciprofloxacin and Caffeine.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Bronchodilator Agents; Caffeine; Ciprofloxacin; Computer Simulation; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Interactions; Female; Humans; Male; Middle Aged; Models, Biological; Precision Medicine; Sex Factors; Theophylline | 2016 |